Interactions between corticosteroids and beta agonists.
作者信息
Taylor D R, Hancox R J
机构信息
Department of Medicine, Dunedin School of Medicine, P O Box 913, Dunedin, New Zealand. stonebow.otago.ac.nz
出版信息
Thorax. 2000 Jul;55(7):595-602. doi: 10.1136/thorax.55.7.595.
Abstract
摘要
相似文献
1
Interactions between corticosteroids and beta agonists.皮质类固醇与β受体激动剂之间的相互作用。
Thorax. 2000 Jul;55(7):595-602. doi: 10.1136/thorax.55.7.595.
2
Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation.皮质类固醇与β-肾上腺素能激动剂在哮喘疾病诱导、进展和加重过程中的相互作用。
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 2):S188-96. doi: 10.1164/ajrccm.161.supplement_2.a1q4-9.
3
Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.长效β2受体激动剂与吸入性糖皮质激素联合治疗哮喘的评估。
Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):933-40. doi: 10.1517/17425250903127226.
4
Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.吸入性β受体激动剂和皮质类固醇治疗对哮喘患者支气管黏膜核转录因子的影响。
Thorax. 1999 Jun;54(6):488-92. doi: 10.1136/thx.54.6.488.
5
[Molecular mechanisms of anti-inflammatory actions of glucocorticoids and their synergy with beta2-agonists].[糖皮质激素的抗炎作用分子机制及其与β2受体激动剂的协同作用]
Pol Arch Med Wewn. 2004 Jun;111(6):743-7.
6
Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.皮质类固醇与肾上腺素能受体激动剂：慢性气道疾病联合治疗的优势
Eur J Pharmacol. 2006 Mar 8;533(1-3):28-35. doi: 10.1016/j.ejphar.2005.12.049. Epub 2006 Feb 7.
7
Interactions of glucocorticoids and beta 2-agonists.
Eur Respir J. 1996 Jan;9(1):160-8. doi: 10.1183/09031936.96.09010160.
8
Benefit-risk assessment of long-acting beta2-agonists in asthma.长效β2受体激动剂治疗哮喘的效益-风险评估
Drug Saf. 2004;27(4):243-70. doi: 10.2165/00002018-200427040-00003.
9
[Refractory asthma: underlying mechanisms, diagnosis and new therapeutic approach].[难治性哮喘：潜在机制、诊断与新治疗方法]
Rev Med Liege. 2008 Jul-Aug;63(7-8):494-9.
10
Pharmacological management of asthma.哮喘的药物治疗
Aust Fam Physician. 1998 Jan-Feb;27(1-2):64-8, 70.
引用本文的文献
1
Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期治疗期间皮质类固醇的使用与血糖结果
Am J Med Open. 2022 Nov 7;8:100027. doi: 10.1016/j.ajmo.2022.100027. eCollection 2022 Dec.
2
The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales.β-受体激动剂在哮喘治疗中的明智策略：作用机制与理论依据
Allergy Asthma Immunol Res. 2024 May;16(3):217-234. doi: 10.4168/aair.2024.16.3.217.
3
Standard medical therapy with vs. without nebulised magnesium for children with asthma decompensation.常规医学疗法联合与不联合雾化吸入镁制剂治疗哮喘急性发作患儿的效果比较。
Eur J Pediatr. 2024 Jun;183(6):2637-2644. doi: 10.1007/s00431-024-05517-3. Epub 2024 Mar 16.
4
Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases.白细胞介素-6在严重急性呼吸综合征冠状病毒2感染和心脏代谢疾病中的不同作用
Cardiol Discov. 2023 Sep;3(3):166-182. doi: 10.1097/CD9.0000000000000096. Epub 2023 Jul 27.
5
Synephrine and Its Derivative Compound A: Common and Specific Biological Effects.辛弗林及其衍生物 A：常见和特定的生物学效应。
Int J Mol Sci. 2023 Dec 15;24(24):17537. doi: 10.3390/ijms242417537.
6
Recent Updates on Corticosteroid-Induced Neuropsychiatric Disorders and Theranostic Advancements through Gene Editing Tools.糖皮质激素诱导的神经精神障碍的最新进展以及通过基因编辑工具实现的诊疗进展
Diagnostics (Basel). 2023 Jan 17;13(3):337. doi: 10.3390/diagnostics13030337.
7
The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription.哮喘管理领域的变化与适当 SABA 处方的需求。
Adv Ther. 2023 Apr;40(4):1301-1316. doi: 10.1007/s12325-022-02410-z. Epub 2023 Jan 30.
8
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation.布地奈德/格隆溴铵/富马酸福莫特罗三联疗法通过抑制 NFκB 活性预防 COPD 小鼠模型的肺动脉高压。
Respir Res. 2022 Jun 27;23(1):173. doi: 10.1186/s12931-022-02081-y.
9
Current Bronchodilator Responsiveness Criteria Underestimate Asthma in Older Adults.现行的支气管扩张剂反应性标准低估了老年人的哮喘情况。
Respir Care. 2020 Aug;65(8):1104-1111. doi: 10.4187/respcare.07132. Epub 2020 Feb 18.
10
Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study.支气管扩张剂和类固醇使用对支气管扩张症-慢性阻塞性肺疾病重叠队列中心脏病和中风风险的影响：一项倾向评分匹配研究
Front Pharmacol. 2019 Nov 27;10:1409. doi: 10.3389/fphar.2019.01409. eCollection 2019.
本文引用的文献
1
Excessive use of inhaled salbutamol: the potential benefits of dose-reduction. A case report.
N Z Med J. 1999 Nov 26;112(1100):448-50.
2
Tolerance to beta-agonists during acute bronchoconstriction.急性支气管收缩期间对β-激动剂的耐受性。
Eur Respir J. 1999 Aug;14(2):283-7. doi: 10.1034/j.1399-3003.1999.14b08.x.
3
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.氟替卡松单药或与沙美特罗联用治疗哮喘与曲安奈德的比较
Chest. 1999 Sep;116(3):625-32. doi: 10.1378/chest.116.3.625.
4
Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Allergy Asthma Proc. 1999 May-Jun;20(3):173-80. doi: 10.2500/108854199778553028.
5
Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.吸入性β受体激动剂和皮质类固醇治疗对哮喘患者支气管黏膜核转录因子的影响。
Thorax. 1999 Jun;54(6):488-92. doi: 10.1136/thx.54.6.488.
6
Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.吸入性β2受体激动剂、吸入性糖皮质激素及其联合用药治疗哮喘的随机试验
Thorax. 1999 Jun;54(6):482-7. doi: 10.1136/thx.54.6.482.
7
Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.在轻度至中度哮喘患者中添加沙美特罗与加倍丙酸氟替卡松剂量的比较。
Thorax. 1999 Mar;54(3):207-12. doi: 10.1136/thx.54.3.207.
8
Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.长期使用常规吸入沙丁胺醇和沙美特罗治疗期间的哮喘控制情况。
Thorax. 1998 Sep;53(9):744-52. doi: 10.1136/thx.53.9.744.
9
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.吸入沙美特罗和氟替卡松：一项比较哮喘单一疗法与联合疗法的研究。
Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65. doi: 10.1016/S1081-1206(10)62606-3.
10
Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.吸入丙酸倍氯米松可恢复对沙美特罗变应原激发保护作用的耐受性。
Chest. 1999 Mar;115(3):629-34. doi: 10.1378/chest.115.3.629.
Zotero 插件